Matches in Wikidata for { <http://www.wikidata.org/entity/Q91610359> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q91610359 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91610359 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91610359 description "scientific article published on 15 February 2019" @default.
- Q91610359 description "wetenschappelijk artikel" @default.
- Q91610359 description "наукова стаття, опублікована в лютому 2019" @default.
- Q91610359 description "գիտական հոդված հրատարակված 2019 թվականի փետրվարի 15-ին" @default.
- Q91610359 name "Current situation and challenges regarding biosimilars in Japan: an example of trastuzumab biosimilars for breast cancer" @default.
- Q91610359 name "Current situation and challenges regarding biosimilars in Japan: an example of trastuzumab biosimilars for breast cancer" @default.
- Q91610359 type Item @default.
- Q91610359 label "Current situation and challenges regarding biosimilars in Japan: an example of trastuzumab biosimilars for breast cancer" @default.
- Q91610359 label "Current situation and challenges regarding biosimilars in Japan: an example of trastuzumab biosimilars for breast cancer" @default.
- Q91610359 prefLabel "Current situation and challenges regarding biosimilars in Japan: an example of trastuzumab biosimilars for breast cancer" @default.
- Q91610359 prefLabel "Current situation and challenges regarding biosimilars in Japan: an example of trastuzumab biosimilars for breast cancer" @default.
- Q91610359 P1433 Q91610359-65EDC551-E452-47F5-B448-6406406B62B6 @default.
- Q91610359 P1476 Q91610359-CDC5F408-0D55-4793-9E86-D2B28E03E51D @default.
- Q91610359 P2093 Q91610359-8C6B4EFE-97CB-4D96-BB4B-A9CE850D0AF2 @default.
- Q91610359 P2093 Q91610359-CD852923-1417-41AD-8768-F257612822AB @default.
- Q91610359 P2093 Q91610359-D3AF8048-DABB-4A32-8C44-87E8191BC785 @default.
- Q91610359 P304 Q91610359-FCA04556-EDD4-4381-8E21-9513265A649F @default.
- Q91610359 P31 Q91610359-83ADC172-AD18-4C8F-86E0-D21DC1B908AB @default.
- Q91610359 P356 Q91610359-C673511B-4923-4360-9F81-65A57EC8540B @default.
- Q91610359 P433 Q91610359-FC2B1C6B-34A0-4D8A-8EBF-333B41F437A0 @default.
- Q91610359 P478 Q91610359-E5F69F69-FB6A-41B9-A7E6-2D4DF8C71773 @default.
- Q91610359 P577 Q91610359-67D3648B-A9A6-4E0D-B333-742820AF72D8 @default.
- Q91610359 P698 Q91610359-912933FF-7224-467F-A0E8-9B14A0747942 @default.
- Q91610359 P921 Q91610359-043C59DD-B9C3-4F06-80D3-C1343797D3BD @default.
- Q91610359 P921 Q91610359-942E5997-669F-4070-8FDF-DF34FEB051C9 @default.
- Q91610359 P356 FON-2018-0957 @default.
- Q91610359 P698 30767568 @default.
- Q91610359 P1433 Q2781597 @default.
- Q91610359 P1476 "Current situation and challenges regarding biosimilars in Japan: an example of trastuzumab biosimilars for breast cancer" @default.
- Q91610359 P2093 "Fumikata Hara" @default.
- Q91610359 P2093 "Kentaro Tajima" @default.
- Q91610359 P2093 "Kosuke Tanabe" @default.
- Q91610359 P304 "1353-1361" @default.
- Q91610359 P31 Q13442814 @default.
- Q91610359 P356 "10.2217/FON-2018-0957" @default.
- Q91610359 P433 "12" @default.
- Q91610359 P478 "15" @default.
- Q91610359 P577 "2019-02-15T00:00:00Z" @default.
- Q91610359 P698 "30767568" @default.
- Q91610359 P921 Q17 @default.
- Q91610359 P921 Q412616 @default.